Individuals with HBsAg-positivity (OR 1.5; 95% CI 1.0–2.4), HBeAg-positivity (OR 5.1; 95% CI 1.1–23.5), and anti-HBc-positivity (OR 1.7; 95% CI 1.3–2.2) were all associated with a higher risk of cervical cancer in the univariable logistic regression analyses (Additional file 2: Table S2). Here, KRT88P is linked to cervical carcinoma.